Navigation Links
Alexza Pharmaceuticals Reports 2010 Third Quarter Financial Results and Provides Business Update
Date:11/9/2010

this obligation as a contingent liability and updates the liability each quarter.  For the three and nine months ended September 30, 2010, respectively, Alexza recorded a non-cash gain of $8.5 million and $7.3 million compared to a gain of $0.7 million for the three and nine months ended September 30, 2009.  The gain in 2010 reflects the reduction in the estimated probability-weighted cash flows from AZ-004 and the estimated timing of receipt of such cash flows, as a result of the CRL received from the FDA, and the termination of the BLS agreements.  Changes in the calculated fair value of this contingent liability are recognized in earnings in the period of the change in estimates.

Alexza anticipates that with current cash, cash equivalents and marketable securities along with interest earned thereon, the proceeds from option exercises and purchases of common stock pursuant to its Employee Stock Purchase Plan, it will be able to maintain its currently planned operations into the second half of 2011; however the Company is not able to accurately predict its 2011 operating expense levels until after the anticipated meeting with the FDA to discuss the CRL.  Changing circumstances may cause Alexza to consume capital significantly faster or slower than currently anticipated.

About Alexza Pharmaceuticals, Inc.Alexza Pharmaceuticals is a pharmaceutical company focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions. Alexza's technology, the Staccato® system, vaporizes unformulated drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. (Click

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  VigeneTech, Inc, ... release of LEGENDplex™ Data Analysis Software, an OEM ... flow cytometers.  BioLegend develops and offers varieties of ... cytometers. With the support of VigeneTech,s data analysis ... accurately analyzed and easily reported ...
(Date:7/28/2014)... , July 28, 2014  A prospective ... Sweden has validated the performance ... platforms and has associated volumetrically assessed breast density ... Cancer Epidemiology, Biomarkers & Prevention (DOI: 10.1158/1055-9965.EPI-13-1219), ... a tool for widespread breast cancer risk assessment," ...
(Date:7/28/2014)... , July 28, 2014  ALPHAEON ... lifestyle healthcare and subsidiary of Strathspey ... acquired Physician Recommended Nutriceuticals (PRN) ® , a ... related products for dry eye and ... a transaction worth up to $55M. ...
Breaking Medicine Technology:VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company 2ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company 3
... DIEGO, Nov. 19 Accumetrics, Inc., developer of the ... reactivity, announces that its market-leading VerifyNow P2Y12 Test was ... which was presented during a Late Breaking Clinical Trials ... The VerifyNow P2Y12 Test is used to measure the ...
... , , HOPKINTON, Mass., Nov. 19 ... a leading provider of tools and services for drug ... partnership between the company,s contract research organization, Caliper Discovery ... to provide customized outsourced medicinal chemistry and in vitro ...
Cached Medicine Technology:VerifyNow(R) System Highlighted in POPular Study Comparing Platelet Reactivity Tests 2Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research 2Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research 3
(Date:7/29/2014)... 2014 Riverdale Urgent Care is making ... Through their presence at local events, partnerships and other ... than just a medical service for the Riverdale neighborhood. ... in support of Riverdale RiverFest and South Riverdale Street ... features local musicians and entertainers, arts and crafts, boat ...
(Date:7/29/2014)... July 29, 2014 Gout was one called ... have proven that last statement essentially moot since many ... people still do not have are the resources to deal ... it costly to maintain treatment for it, but the effects ... activities to a grinding halt. , Alternative medicine ...
(Date:7/29/2014)... July 29, 2014 PeopleKeys today announced ... to teach students how to train and certify others ... Certified Behavioral Consultant Trainer , will be taught by ... of Training John Schindell as a live Tele-course over ... , The Certified Behavioral Consultant Trainer course will use ...
(Date:7/29/2014)... Tucson, Arizona (PRWEB) July 29, 2014 ... addition to an employer’s benefits package, or health and ... healthy work-life balance while providing an effective way for ... to take advantage of the program, employees specify the ... Vacation Savings Account. , An employer benefits from offering ...
(Date:7/29/2014)... July 29, 2014 The Multiple System ... has announced the appointment of five new members to ... Coalition announced the election of its executive directors. ... Board members and 2 Physician Advisors. These 12 ... Coalition mission of education, support, advocacy and research funding ...
Breaking Medicine News(10 mins):Health News:Riverdale Urgent Care of the Bronx, NY Puts a Face Back on Medicine 2Health News:Riverdale Urgent Care of the Bronx, NY Puts a Face Back on Medicine 3Health News:Gout Natural Remedy Report Review | The Ultimate Secret to Eliminating Gout Naturally – Vinamy.com 2Health News:PeopleKeys Announces New Certified Behavioral Consultant Trainer Course 2Health News:PeopleKeys Announces New Certified Behavioral Consultant Trainer Course 3Health News:Outski launches 401(play)™ Plan to Employers as Part of an Employee Benefit / Health and Wellness Program 2Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 2Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 3Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 4
... PAUL, Minn Call it a stroke of bad luck ... brought very good news for middle aged women. Women are ... to be due to expanding waist lines and heart disease. ... over the age of 18 who participated in the National Health ...
... disasters have been in the spotlight especially after recent ... specialists, well planned crisis management strategies are need of ... undergoing regular dialysis are not in dire straits due ... ,The July Clinical Journal of the ...
... icebergs have a major impact on the ecology of ... life, according to a new study by American researchers. ... they release far out at sea as they melt. ... nutrients, chlorophyll and krill out to a radius of ...
... who suffer bouts of nausea and vomiting during their pregnancies ... but it seems that going through morning sickness is a ... who have conducted a new study and found that women ... risk of developing breast cancer later in life than expecting ...
... hit out at media reports claiming that the she admitted to ... written on her Myspace blog was made up and not written ... blog. Someone made it up, Contactmusic quoted Allen, as saying. ... in a Canada TV show was misinterpreted by someone and was ...
... Wockhardt Hospital, Bangalore, have removed a large cancerous tumour from ... a statement that Prabhu Ram was diagnosed to be ailing ... led to difficulty in breathing, high fever and swelling of ... tumour arising from both the upper chambers of the heart, ...
Cached Medicine News:Health News:Stroke - Unfair to the Middle-aged Fair Sex 2Health News:Nephrologists Reassess Disaster Response Strategies 2Health News:Nephrologists Reassess Disaster Response Strategies 3Health News:Morning Sickness may Signify Lower Breast Cancer Risk 2Health News:Morning Sickness may Signify Lower Breast Cancer Risk 3
Halogen-free immersion oil based on ester oil....
Immersion oil composed on polyester polyol, diphenyl cresyl phosphate and tricyclodecane dimethanol....
Immersion oils may crystallize on storage. Can be redissolved on heating to 50ºC (1-2 hours)...
... The CoaguChek XS system is a compact, ... patients to experience a significant improvement in ... management of their condition. , , The ... to the proven CoaguChek S system. It ...
Medicine Products: